Manage Your Liver

What liver doctors will not tell you: ALT is the key

What liver doctors will not tell you: ALT is the key

Whether you have fatty liver, NASH, Hepatitis B, Hepatitis C, drug related liver damage, or alcohol liver disease, ALT (Alanine Aminotransferase / SGPT) level is the primary indicator of liver health. As long as your ALT level remains normal, liver health is ensured. Other liver function test results such as AST (Aspartate Aminotransferase / SGOT) are only secondary. 


This is because ALT is an enzyme that is mainly found in the liver. ALT enzymes are normally contained within the liver cells when the liver is healthy, but when the liver cells are injured or damaged by whatever reasons, the ALT enzymes are released into the bloodstream, causing levels to go up.  Therefore, we can measure the concentration of ALT enzymes in the blood to determine the degree of liver damage.


On the other hand, although AST is a liver enzyme, it can also be found in other organ tissues such as the heart, muscle, kidney, and brain. Therefore, when compared with ALT, AST is less specific to liver injury. AST alone is not able to effectively reflect the health status of the liver, they are usually used in conjunction with ALT to detect liver injury.


Therefore, whether you have fatty liver or hepatitis, the main concern is not how much fat is in your liver or how high your viral load is. Instead, the KEY is to ensure your ALT level is kept within the normal range as normal ALT level indicates that the liver is healthy.


Having a small amount of ALT in the bloodstream is normal for healthy individuals. The normal values are around 10-40 units per litre. This range might vary according to different countries or laboratories, but the upper limit is usually between 35~45. A higher than normal level of ALT indicates the liver is damaged or inflamed, thus it is important to always maintain a normal ALT level. 


More about lowering ALT level:
Blood Test Report :: YHK improves ALT level and liver function for hepatitis C cirrhosis patient

  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
About 2.7 million persons in the United States are infected with hepatitis C virus in their blood. The majority of these individuals remain asymptomatic for many years following the initial infection, and many people can even live their whole life with hepatitis C virus in their body without knowing they are infected. On the other hand, some carriers will develop chronic hepatitis C, meaning that the virus in their body attacks the liver, causing liver damage with elevated alan
Since the introduction of direct-acting antiviral (DAA) therapy, treatment for hepatitis C (HCV) was revolutionized, as patient outcomes are improved with fewer side effects and high cure rate. However, there is significant debate in the society based on studies that suggest HCV cure does not eliminate risk for hepatocellular carcinoma (HCC) or liver cancer. Other research suggests the possibility of increased risk of developing liver cancer during and after DAA treatment in patients with hep
Hit Questions
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
Hepatitis C viruses share a common characteristic to other chronic liver diseases; it could damage the patients’ liver cells. Hepatitis C patients should focus on stopping or reducing the damage in the liver, and this focus should be the same for other chronic liver diseases e.g. hepatitis B, fatty liver disease, NASH etc. And this is exactly what YHK can do.   YHK can stop liver cells damage caused by hepatitis viruses, and can repair damaged liver cells, to he
YHK Liver Therapy
Your Liver

starts here.
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us